Groupe Bruxelles Lambert SA

OTCPK:GBLB.F Stock Report

Market Cap: US$8.9b

Groupe Bruxelles Lambert Valuation

Is GBLB.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GBLB.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GBLB.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GBLB.F's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GBLB.F?

Key metric: As GBLB.F is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GBLB.F. This is calculated by dividing GBLB.F's market cap by their current revenue.
What is GBLB.F's PS Ratio?
PS Ratio1.3x
Sales€6.62b
Market Cap€8.40b

Price to Sales Ratio vs Peers

How does GBLB.F's PS Ratio compare to its peers?

The above table shows the PS ratio for GBLB.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
CODI Compass Diversified
0.8x8.5%US$1.8b
CNNE Cannae Holdings
2.8x1.9%US$1.3b
MPCF.F Metro Pacific Investments
1.4xn/aUS$1.4b
FMCC Federal Home Loan Mortgage
0.4x-2.9%US$7.9b
GBLB.F Groupe Bruxelles Lambert
1.3x-18.3%US$8.4b

Price-To-Sales vs Peers: GBLB.F is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (1.3x).


Price to Sales Ratio vs Industry

How does GBLB.F's PS Ratio compare vs other companies in the US Diversified Financial Industry?

15 CompaniesPrice / SalesEstimated GrowthMarket Cap
RKT Rocket Companies
0.5x23.3%US$26.93b
UWMC UWM Holdings
0.4x9.5%US$10.02b
FMCC Federal Home Loan Mortgage
0.4x-2.9%US$7.92b
LDI loanDepot
0.4x18.5%US$742.29m
GBLB.F 1.3xIndustry Avg. 2.8xNo. of Companies17PS0246810+
15 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GBLB.F is good value based on its Price-To-Sales Ratio (1.3x) compared to the US Diversified Financial industry average (2.7x).


Price to Sales Ratio vs Fair Ratio

What is GBLB.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GBLB.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.3x
Fair PS Ratio2.8x

Price-To-Sales vs Fair Ratio: GBLB.F is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GBLB.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$69.76
US$95.06
+36.3%
10.4%US$105.82US$77.25n/a6
Nov ’25US$72.75
US$96.94
+33.2%
10.4%US$107.91US$78.77n/a6
Oct ’25US$77.44
US$96.94
+25.2%
10.4%US$107.91US$78.77n/a6
Sep ’25US$76.46
US$96.94
+26.8%
10.4%US$107.91US$78.77n/a6
Aug ’25US$74.66
US$96.94
+29.8%
10.4%US$107.91US$78.77n/a6
Jul ’25US$71.75
US$97.76
+36.3%
7.2%US$108.83US$84.88n/a6
Jun ’25US$76.50
US$97.44
+27.4%
7.3%US$108.06US$84.29n/a6
May ’25US$72.09
US$97.44
+35.2%
7.3%US$108.06US$84.29n/a6
Apr ’25US$75.61
US$97.44
+28.9%
7.3%US$108.06US$84.29n/a6
Mar ’25US$73.05
US$95.75
+31.1%
8.7%US$108.08US$84.31n/a6
Feb ’25US$74.40
US$96.35
+29.5%
8.1%US$108.34US$84.51n/a7
Jan ’25US$79.00
US$96.35
+22.0%
8.1%US$108.34US$84.51n/a7
Dec ’24US$77.34
US$97.31
+25.8%
6.8%US$107.23US$85.25US$68.886
Nov ’24US$72.50
US$102.66
+41.6%
6.4%US$112.69US$94.09US$72.756
Oct ’24n/a
US$102.66
0%
6.4%US$112.69US$94.09US$77.446
Sep ’24US$79.80
US$102.66
+28.6%
6.4%US$112.69US$94.09US$76.466
Aug ’24n/a
US$103.33
0%
6.0%US$113.12US$96.10US$74.666
Jul ’24US$79.00
US$100.29
+27.0%
4.7%US$107.12US$93.73US$71.754
Jun ’24US$77.66
US$102.41
+31.9%
5.2%US$108.77US$94.23US$76.505
May ’24US$89.38
US$103.32
+15.6%
5.8%US$109.60US$93.10US$72.095
Apr ’24US$84.23
US$103.32
+22.7%
5.8%US$109.60US$93.10US$75.615
Mar ’24US$82.76
US$104.66
+26.5%
8.9%US$113.76US$87.76US$73.055
Feb ’24US$85.36
US$104.66
+22.6%
8.9%US$113.76US$87.76US$74.405
Jan ’24US$77.89
US$102.11
+31.1%
8.2%US$110.53US$85.26US$79.006
Dec ’23US$80.93
US$102.11
+26.2%
8.2%US$110.53US$85.26US$77.346

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies